Global Hematology Analyzer Market to expand with 5.85% CAGR during 2018-2023

November 14, 2019


According to the latest study titled ‘Global Hematology Analyzer Market: Analysis By Type (3-part, 5-part, 6-part), By Modality (POC, Standalone), By End User, By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)’ available at MarketStudyReport.com, the global hematology analyzer market is estimated to grow with a CAGR of 5.85% through the year 2023.
 

Hematology analyzer are devices used to conduct tests on blood samples to analyze WBC, RBC, hemoglobin, platelet counts, and hematocrit levels. Factors such as advancements in analytical abilities, rise in demand for devices with minimum operator intervention, and increasing adaptability of electronic medical record systems are driving the growth of hematology analyzer market.
 

The study encompasses details about market size based on revenue shares and growth opportunities for individual segments. It analyses the competitive landscape of the hematology analyzer market using SWOT analysis and Porter’s Five Force analysis methods. Information about the market dynamics covering drivers and restraints is also outlined in the report. 
 

Based on type, hematology analyzer market is segmented into 3-part, 5- part and 6-part differential hematology analyzer. The 3-part differential hematology analyzer segment is presumed to register the largest share in the upcoming years. While based on modality, the industry is divided into point-of-care hematology analyzer and standalone hematology analyzer.
 

In terms of end-user spectrum, the hematology analyzer market is split into diagnostics laboratories, hospitals, and others, wherein, the hospital segment is anticipated to provide the maximum revenue to the hematology analyzer manufacturers over the forecast period.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1436653/
 

Considering the geographical landscape, the global hematology analyzer market is fragmented into regions including Europe, North America, Asia Pacific, and rest of world. As per the report, North America hematology analyzer market registered the largest share in 2017, owing to presence of huge patient base and highly advanced medical infrastructure. 
 

Some of the vendors operating in the global hematology analyzer market are Nihon Kohden, Sysmex, HORIBA, Boule Diagnostics, Abbott Laboratories, Beckman Coulters, EKF Diagnostics, Siemens, Drew Scientific, Bio-Rad, and BioSystems.


Frequently Asked Questions (FAQ) :

Based on type, the hematology analyzer market is segmented into 3-part, 5- part and 6-part differential hematology analyzer. While based on modality, the industry is divided into point-of-care hematology analyzer, and standalone hematology analyzer.
Factors such as advancements in analytical abilities, rise in demand for devices with minimum operator intervention and increasing adaptability of electronic medical record system are driving the growth of hematology analyzer market.
The global hematology analyzer market is estimated to grow with a CAGR of 5.85% through the year 2023.
Companies that are part of the competitive landscape of the hematology analyzer market are Nihon Kohden, Sysmex, HORIBA, Boule Diagnostics, Abbott Laboratories, Beckman Coulters, EKF Diagnostics, Siemens, Drew Scientific, Bio-Rad, and BioSystems.